Data & AI Analyst

Stichting PharmAccess International (commonly known as PharmAccess) is a Dutch foundation that develops and implements health-sector interventions that combine digital technology, financing mechanisms, quality improvement services and public–private partnerships to expand access to affordable, quality healthcare in low- and middle-income countries. Operating as a foundation, PharmAccess acts as a program and innovation hub that brings together donor agencies, governments, private healthcare providers, insurers, digital platform developers and social investors to design and scale models that seek to strengthen health systems and enable patients to access services through more predictable financing and measurable quality standards. At its core, PharmAccess pursues an integrated approach that links health financing instruments with digital tools and provider-level quality improvement. The foundation’s activities are organized around a set of interrelated program lines and delivery vehicles: digital health platforms that enable patient enrollment, payments and data collection; targeted financing mechanisms that provide loans, insurance schemes or blended capital to health providers and patients; and quality assurance and improvement services that assess, score and upgrade clinical and facility management practices. The approach emphasizes the use of data and digital workflows to increase transparency, improve accountability for funds and outcomes, and reduce barriers to access for underserved populations. PharmAccess is widely known for launching or incubating several flagship initiatives that translate these principles into operational products and services. One prominent initiative is M-TIBA, a mobile health wallet and digital health financing platform developed in collaboration with partners; M-TIBA facilitates the collection, management and spending of funds earmarked for healthcare on mobile phones, enabling patients, employers, donors and insurers to channel payments to accredited providers while tracking utilization and outcomes. Another significant vehicle is the Medical Credit Fund (MCF), an impact investment facility that offers loans, technical assistance and investment advisory services to small- and medium-sized private healthcare providers in order to expand service capacity and upgrade quality; MCF blends commercial financing with social underwriting to reach providers who otherwise lack access to working capital for facility improvements, equipment and working capital. Quality improvement is implemented through the SafeCare program (a standards-based quality improvement methodology), which provides stepwise assessments, improvement plans and coaching to health facilities to achieve internationally recognized, auditable quality levels. SafeCare combines on-site assessments with digital scorecards and benchmarking tools so that providers, payers and investors can objectively judge facility performance and progress. The SafeCare methodology is intended to create objective, comparable data points that can be used by lenders and insurers to underwrite risk or set contracting conditions, and by governments and donors to direct capacity-building support. PharmAccess also works in the broader health financing and policy space. The foundation designs and manages donor-funded health insurance and public-private contracting programs, helps governments and insurers introduce performance-based and risk-pooling mechanisms, and supports monitoring and evaluation systems that rely on digital data flows. Through these activities, PharmAccess seeks to demonstrate financially sustainable pathways for scaling access to primary and essential health services that protect households from catastrophic out-of-pocket spending while creating viable market opportunities for quality-focused private providers. Technology and data play an explicit enabling role across all PharmAccess products and services. The foundation invests in interoperable digital platforms, mobile payment integrations and analytics tools that collect anonymized utilization and financial data to measure impact and inform iterative program design. These digital layers are intended to strengthen claim management, patient identification and referral systems, and provider performance management. PharmAccess often partners with technology companies, mobile network operators and local fintech firms to integrate payments, beneficiary enrollment and provider reporting functionality into country programs. Operationally, PharmAccess works across several countries in sub-Saharan Africa and has collaborated with national ministries of health, multilateral donors and local health-sector stakeholders to adapt program components to local regulatory and market conditions. Its financing products, technical assistance services and digital solutions are typically piloted in partnership with local providers and scaled through blended finance arrangements or government-led contracting. The foundation combines philanthropic and donor financing with private capital to demonstrate blended models that can be taken to scale by other funders and public systems. PharmAccess is governed as a Dutch foundation (stichting) and positions itself as a facilitator and implementer rather than as a commercial provider. It frequently enters into consortiums with implementers, technology vendors, insurers and investors to deliver end-to-end solutions that span financing, digital connectivity and in-facility quality improvement. Across its portfolio, PharmAccess emphasizes measurable outcomes—utilization increases, financial protection for households, and measurable improvements in facility quality—and publishes program findings and operational lessons to inform policy and replication. Key beneficiaries of PharmAccess programs include low- and middle-income patients seeking affordable care, private and informal health providers gaining access to capital and quality tools, governments seeking scalable payment and contracting solutions, and donors focused on sustainable health-system improvements. By combining digital health tools, social finance, and standards-based quality programs, Stichting PharmAccess International aims to create practical, evidence-driven models that make markets work better for health while generating the data needed for continuous improvement and scale.